Skip to content
    Compare notes on r/BodyHackGuideCompare notes with other researchers. Join r/BodyHackGuide

    Orforglipron vs SLU-PP-332

    Side-by-side comparison of Orforglipron and SLU-PP-332: mechanism, half-life, dose range, safety profile, and vendor pricing.

    Orforglipron from $249.99
    SLU-PP-332 from $69.99

    Price snapshot

    Orforglipron

    Current low
    $249.99
    current listings
    7-day low
    —
    not enough history yet
    30-day low
    —
    not enough history yet
    30-day change
    —
    not enough history yet

    SLU-PP-332

    Current low
    $69.99
    current listings
    7-day low
    —
    not enough history yet
    30-day low
    —
    not enough history yet
    30-day change
    —
    not enough history yet

    Orforglipron

    Orforglipron (also known as LY3502970) is Eli Lilly's oral, non-peptide, small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist, approved in the US for weight management and submitted to the FDA for type 2…

    Lowest listed price: $249.99 across 1 listing

    Full Orforglipron profile

    SLU-PP-332

    SLU-PP-332 is the first-generation synthetic pan-agonist of the estrogen-related receptors (ERRα, ERRβ, ERRγ) developed by the laboratory of Thomas Burris at Saint Louis University and reported in a landmark 2023…

    Lowest listed price: $69.99 across 5 listings

    Full SLU-PP-332 profile

    Side-by-side comparison

    Attribute Orforglipron SLU-PP-332
    Category Weight Loss Performance
    Research Stage FDA Approved Preclinical
    Mechanism of Action Orforglipron (LY3502970; OWL833) is an oral, non-peptide (small-molecule) GLP-1 receptor agonist. It engages the GLP-1 receptor (GLP1R) through a binding mode fundamentally different from native GLP-1 or peptide-based analogs. Non-Peptide Binding at a Distinct… SLU-PP-332 acts through pan-agonism of the three estrogen-related receptors (ERRα/NR3B1, ERRβ/NR3B2, ERRγ/NR3B3), a subfamily of orphan nuclear receptors that regulate oxidative metabolism, mitochondrial biogenesis, and exercise-responsive gene expression. The…
    Half-Life ~29-49 hours (supports once-daily oral dosing) —
    Typical Dose Range — Research compound — no established human doses. Animal studies: 10-50 mg/kg
    Dosing Frequency Once daily —
    Administration — —
    Side Effects Orforglipron's side effect profile closely mirrors the GLP-1 receptor agonist class as a whole, dominated by gastrointestinal effects that typically improve with continued dosing and proper titration. Common Gastrointestinal Effects (incidence 20-50% depending… The side effect profile of SLU-PP-332 in humans is undocumented because no clinical trials have been conducted. Rodent studies report generally acceptable tolerability at doses producing exercise-mimetic metabolic effects, without overt signs of toxicity on…
    Molecular Weight 882.97 g/mol 290.3 g/mol
    Common Vial Sizes — —

    Price tracking

    Tracking Orforglipron prices since April 6, 2026. Trend chart unlocks once we have price snapshots from more than one day.

    Price History

    3 data points
    • Half Nattys
    • Ion Peptide
    • BHG Labs

    Orforglipron: potential benefits

    • No structured benefit list published.

    SLU-PP-332: potential benefits

    • Exercise mimicry without physical exertion
    • Enhanced fat oxidation
    • Increased mitochondrial biogenesis
    • Improved endurance capacity
    • Muscle fiber type conversion
    • Metabolic health improvement

    Frequently asked

    What's the difference between Orforglipron and SLU-PP-332?

    Orforglipron is a weight loss that orforglipron (ly3502970; owl833) is an oral, non-peptide (small-molecule) glp-1 receptor agonist. it engages the glp-1 receptor (glp1r) through a binding mode fundamentally…. SLU-PP-332 is a performance that slu-pp-332 acts through pan-agonism of the three estrogen-related receptors (errα/nr3b1, errβ/nr3b2, errγ/nr3b3), a subfamily of orphan nuclear receptors that regulate oxidative…. The two differ in mechanism, half-life (~29-49 hours (supports once-daily oral dosing) vs not reported), and typical dose range.

    Which has the longer half-life, Orforglipron or SLU-PP-332?

    Orforglipron has a half-life of ~29-49 hours (supports once-daily oral dosing). SLU-PP-332 has a half-life of not reported. Longer half-lives generally mean less frequent dosing but slower on/off kinetics.

    Which is cheaper, Orforglipron or SLU-PP-332?

    Lowest listed price on BodyHackGuide: Orforglipron from $249.99, SLU-PP-332 from $69.99. Prices are pulled from the vendor listings tracked on BHG and change frequently. See the compare tables on each compound page for the current set of offers.

    Can you stack Orforglipron and SLU-PP-332?

    Stacking depends on mechanism overlap, safety profile, and goals. Orforglipron and SLU-PP-332 should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.

    See current vendor prices

    Listings from the vendors we track. Prices change often, so check the vendor before you buy.

    Orforglipron prices SLU-PP-332 prices Compare all compounds

    Before you buy Orforglipron or SLU-PP-332

    Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.

    View Vendor Scorecard

    Related comparisons

    Orforglipron vs Semaglutide

    Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.